Skip to main content

News

head uk2

News

HMC-0309-041Get more information about:

  • Chitin and chitosan on the world wide web
  • Company news
  • Events
  • Publications and releases
  • Tips and tricks

Enjoy reading!

Chitosan microparticles for the treatment of HIV-1 infection

Small interferring RNAs (siRNAs) can inactivate viruses by so-called gene silencing. In order to use this process in biomedicine, the transport of unstable siRNAs must be improved. In the presented study, siRNAs are coupled to chitosan microparticles and investigated for the inactivation of viral proteins in HIV-1 infected C8166 cells. siRNA transfection mediated by chitosan microparticles for the treatment of HIV-1 infections of human cell lines

drug delivery, chitosan, HIV-1, microparticle, siRNA Transfection

Re-certification successfully passed

HMC has successfully passed its re-certification to ISO 13485:2016 for the design and development, manufacture and distribution of chitin, chitosan and chitosan derivatives for medical devices. Our current certificate is valid until November 2024. You can get it in our download area.

Certificate

Contact

  • Heppe Medical Chitosan GmbH
    Heinrich-Damerow-Strasse 1
    06120 Halle (Saale)
    Germany
  • Tel.: +49 (0) 345 27 996 300
    Fax: +49 (0) 345 27 996 378
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.